Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients
- 18 February 2024
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 556, 117831
Abstract
No abstract availableKeywords
Funding Information
- National Research Council of Thailand
This publication has 31 references indexed in Scilit:
- Exposure to volatile organic compounds is a risk factor for diabetes: A cross-sectional studyChemosphere, 2023
- Smelling the Disease: Diagnostic Potential of Breath AnalysisMolecular Diagnosis & Therapy, 2023
- Exhaled volatile organic compounds for diagnosis of hepatocellular carcinomaScientific Reports, 2022
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- Hepatocellular carcinomaNature Reviews Disease Primers, 2021
- Lipid metabolism in cancer progression and therapeutic strategiesMedcomm, 2020
- Advances in the early diagnosis of hepatocellular carcinomaGenes & Diseases, 2020
- Breath Metabolomics Provides an Accurate and Noninvasive Approach for Screening Cirrhosis, Primary, and Secondary Liver TumorsHepatology Communications, 2020
- Investigating the breath metabolome as a diagnostic tool for hepatocellular carcinoma in cirrhotic patientsHPB, 2018
- Diagnostic potential of breath analysis—focus on volatile organic compoundsClinica Chimica Acta, 2004